摘要
绝经后妇女骨质疏松发展迅速,与机体雌激素缺乏有关。研究表明雌激素在骨吸收与改建中发挥了极其重要的作用,雌激素缺乏可以引起全身骨质疏松。牙槽骨是机体骨质密度较低的骨组织,最容易出现骨质疏松,临床上主要表现为牙槽骨吸收,导致牙齿松动与脱落,直接影响患者牙齿与牙周组织健康与口腔治疗,但至今对牙槽骨吸收与改建的机理并不十分明确。牙槽骨骨质疏松及吸收是否受雌激素缺乏的影响,目前的报道尚有争论,使得研究骨质疏松状况下牙周组织的生理、病理特点成为涉及牙周病学、牙槽外科、牙齿种植、口腔修复及正畸治疗等口腔多学科的临床问题,也是本研究所关注的问题。
人牙周膜中的成纤维细胞( Human Periodontal Ligament Fibroblast,HPLF)是最主要的细胞成分,牙周膜成纤维细胞通过增殖、分化、分泌基质参与到牙周组织的改建中,在维持牙周组织完整性以及行使牙周改建的功能中发挥重要的作用,而雌激素在其中发挥的作用是我们关心的问题。国内外学者的研究提供了雌激素对HPLF增殖、分化影响的一些线索,如雌激素作用下牙周膜成纤维细胞可以表现出一定的成骨特性,例如分泌骨相关蛋白,以及形成矿化结节等,但其作用途径尚未阐明。
雌激素受体(estrogen receptor,ER)是雌激素的细胞内结合位点,是雌激素发挥作用的关键所在。在机体其他组织和器官,雌激素通常是通过与其特异性受体结合发挥调控细胞生长、增殖和分化的。ER的两种亚型ERα和ERβ已经成功分离出来,在不同的组织中有不同的表达型。目前国内外关于ER与牙周组织关系方面的研究较少。
雌激素可能能够影响牙周膜成纤维细胞的一些生物学特性,例如蛋白合成和细胞生长,也可能对成纤维细胞成骨分化有一定影响,通过本研究我们希望进一步探讨雌激素对牙周改建的生理作用,为临床正畸治疗和牙周病的治疗提供一定的实验依据。
我们通过(1)切除SD大鼠两侧卵巢(OVX),建立人工模拟绝经后的动物模型,观察大鼠牙槽骨高度(临床附着丧失)和血清雌激素水平的关系;(2)取大鼠下颌磨牙区组织,制备冰冻切片后,用免疫组织化学SABC法进行牙周组织ERα、ERβ染色,计数随机区域中阳性细胞个数并进行统计学分析。(3)取因正畸原因拔除的第一前磨牙牙周膜组织,用组织块结合酶消化法培养牙周膜成纤维细胞,制作细胞爬片,免疫细胞化学进行ERα、ERβ染色,逆转录聚合酶链式反应(RT-PCR)法检测ER的mRNA的表达,Western blot法分析ER蛋白的表达;(4)对体外培养的牙周膜成纤维细胞给与不同生理浓度的雌激素刺激,以3H-胸腺嘧啶和3H-脯氨酸参入实验确定细胞DNA和胶原合成产物的变化,明确雌激素对细胞增殖的影响;(5)在不同生理浓度的雌激素刺激下,测定细胞碱性磷酸酶活性(ALP)和骨钙素(OCN)含量,明确雌激素对细胞骨分化能力的影响。
研究结果发现:
(1)去势组大鼠下颌第二磨牙区可见牙槽骨皮质变薄,骨小梁变稀疏,排列紊乱,骨髓腔隙增大,骨小梁表面成骨细胞及破骨细胞均有增加。牙周膜水肿、疏松,排列不规则,血管扩张充血,牙骨质密度也有减低,较假手术组明显呈退行性变,临床附着水平也与假手术组有统计学差异(P<0.01),而雌激素治疗组可改善这一病理变化。这与动物血清雌激素浓度有明显的相关性。
(2)大鼠牙周膜组织切片中,可见ER阳性染色的棕黄色颗粒,PBS空白对照组则无棕黄色染色,阳性对照可见强阳性染色。观察发现ERα、ERβ在SD大鼠牙周组织中比较广泛的表达,ER在细胞胞核和胞浆均有表达,ERβ的阳性率明显高于ERα。
(3)体外培养人牙周膜成纤维细胞制备细胞爬片,通过免疫细胞化学方法可观测到ERα、ERβ在胞核中表达。
(4)通过RT-PCR检测ERmRNA,各组细胞用雌激素受体的特异性引物均获得了目的PCR产物,分别对应ERα、ERβ的特异条带
(5)同株细胞经Western blot检测结果,各组细胞可见正确分子量的蛋白印迹条带,其中ERβ的条带较ERα对应的蛋白条带浓。
(6)以10-7, 10-8和10-9mol/L浓度的E2作用于细胞,与阴性对照和空白对照组相比,各种浓度的雌激素均未增加细胞DNA的合成量和胶原合成(P>0.05)
(7)体外培养牙周膜成纤维细胞用浓度为10-7、10-8、10-9mol/L的E2分别处理,与空白对照组相比,E2浓度依赖地增加细胞内ALP活性和OCN的含量,受体特异性阻断剂ICI182780可以阻断这一效应。
根据以上研究结果,得出以下结论:
(1)雌激素缺乏时动物牙槽嵴高度降低,骨量减少,附着丧失增加,而给予去势后大鼠补充雌激素,牙槽骨的骨密度增加,附着丧失减轻,表明雌激素对于改善骨质疏松具有一定作用。
(2)大鼠牙周膜中,可观察到ER免疫组化阳性的细胞,结合细胞分布特点,可以得出成纤维细胞中有雌激素受体表达的结论。说明牙周组织对雌激素有直接应答反应。ERα和ERβ阳性率分别为20%和40%左右,二者间有显著性差异(P<0.05),说明在大鼠的牙周膜以ERβ的表达为主。
(3)体外培养的人牙周膜成纤维细胞中也可观察到ER两种亚型的表达。RT-PCR法和Western blot法分别从mRNA水平和蛋白水平证实了ERα、ERβ在HPLF上均有表达。提示雌激素在HPLF的增殖、分化中发挥作用很可能是通过配体—受体途径实现的
(4)生理浓度的雌激素对牙周膜成纤维细胞的胶原和DNA合成没有影响,说明雌激素-受体复合体作用的基因可能与细胞的增殖和胶原合成无关。
(5)生理浓度的雌激素能促进牙周膜成纤维细胞合成和释放细胞成骨分化的指标ALP和OCN,说明雌激素能够促进牙周膜成纤维细胞向成骨方向分化,这对于维持牙周组织正常的改建和损伤后的修复有重要的意义。
Estrogen deficiency, which is important in the pathogenesis of postmenopausal osteoporosis, has received increasing attention in the studies related to the periodontal diseases in postmenopausal women, such as the alveolar bone resorption and clinical attachment loss. Accumulating evidences have demonstrated that osteoporotic women exhibited a higher frequency of bone turnover, as observed in the femur. In the ovariectomized rat model, estrogen induced similar activation of bone resorption with increased. Although there is no doubt that estrogen has a broad influence in the biology of various human tissues, the etiology of estrogen-associated periodontal diseases remains an enigma. Therefore, we hypothesize that estrogen may play an important role in the maintenance and regeneration of periodontal tissue.
The periodontal ligament is the connective tissue located between the alveolar bone and root surface of the tooth. Periodontal ligament cells (PDLcs) play an important part in maintaining the integrity of the periodontal tissue. PDLcs are capable of differentiating into osteogenic cells and exhibit osteoblastic phenotypes, such as the production of bone-like matrix proteins, high alkaline phosphatase (ALP) activity, and the formation of calcified nodules. It is well known that estrogen affects the biological properties of osteogenic cells such as the production of osteocalcin and ALP activity. However, less information is available regarding the effect of estrogen on PDLcs. Better understanding the mechanisms of estrogen on periodontium would facilitate our effort in the maintenance of the health of postmenopausal periodontal tissue.
The sex hormones exert their influence on target tissues by binding to specific receptors that belong to a superfamily of ligand-activated transcription factors that regulate cell growth, differentiation and development. Two estrogen receptor (ER) subtypes, designated ER-alpha and ER-beta, have been identified and these receptors show a tissue specific expression pattern. When investigating the effects of estrogen on PDLc, it is critical to exam whether ER is expressed in PDLc. Since human osteoblasts express ERs, it is possible that PDLcs also do so. Since it was quite controversial that whether PDLcs express ERs in previous reports, more evidences are needed to assess the expression and functional significance of ER in PDLcs.
In the present study, we established animal model by bilateral ovariectomy (OVX) and examined the effect of estrogen deficiency on the alveolar bone metabolism and the change of serum estrogen; investingated the ERs expression in periodontal ligament of rat by histoimmunochemistry. By the culture of human periodontal ligament cells ,we investigated ERs expression in human PDLc by cytoimmunochemistry, ERs mRNA expression by RT-PCR and ERs protein expression by western blotting, and further evaluated the influence of estrogen on DNA and collagen synthesis and the potential action of estrogen on bone-forming in PDLc.
We found that:
(1) Significant alveolar bone loss was detected in OVX group, indicating the success of the animal model. Estrogen replacement treatment (ERT) clearly attenuated the bone loss by the deficiency of estrogen induced by OVX. In rats of OVX + vehicle, as expected, the average serum 17-beta estradiol level was significant lower than that in OVX + 17-beta estradiol and sham.
(2) By histoimmunochemistry, ERαand ERβwere abundantly expressed in periodontal ligament, and ERβwas much more than ERα(p<0.01). ERs were localized in both nuclei and cytoplasms, which indicates estrogen may play its role by different mechanisms in periodontium.
(3)After successful culture of primary human periodontal ligament cells, both ERαand ERβprotein expressions were found in the cells by specific antibody by cytoimmunochemistry.
(4)ERs mRNA was examined by RT-PCR. The expected PCR products of ER-alpha in 287bp and ER-beta in 659bp respectively were obtained from the primary cultured PDLcs. We found that the PDLcs did express both ER subunit ER-alpha and -beta although the intensities of the HER-alpha and -beta bands were much weaker than those observed in positive control MCF-7 cells. The results suggested that ER mRNA expression in PDLcs is in relative low level.
(5)The protein expressions of ERs were also determined by Western Blot analysis. Similar expressions in low levels of ERs were detected compared to the positive control of MCF-7 cell extract. However, no difference was detected in ERs expression after 17-beta estradiol treatment.
(6)When PDLcs were incubated in the presence of 17-beta estradiol, neither periodontal ligament cell DNA synthesis nor collagen synthesis was affected by E2 treatment for 24 hours.
(7) Both ALP activity and osteocalcin production were increased by 17-beta estrodiol in a dose-dependent manner. Estrogen receptor antagonist ICI 182780 (10-6mol/L) completely blocks the effect of 17-beta estradiol. The results suggested that PDLcs mediates estrogen bone-sparing action through ER, therefore contributes to the mechanisms of estrogen deficiency alveolar bone loss.
In conclusion:
(1)Our results suggested that estrogen deficiency induced by ovariectomy significantly accelerated alveolar bone loss whereas ERT could efficiently reverse the process,confirmed that there existed obvious correlation between estrogen level and periodontal health.
(2) both ER-alpha and ER-beta were expressed in PDLcs providing the bases that the ERs may be involved in the pathology mechanism of alveolar bone loss in postmenopausal women.
(3) There was no effect on periodontal ligament cell DNA synthesis and collagen synthesis by treatment with E2. The genes regulated by the estrogen–ER complex in periodontal ligament cells remain to be identified these genes are probably not associated with periodontal ligamentcell proliferation and collagen formation.
(4) estrogen could exhibit obvious positive modulation on ALP activity and osteocalcin production in PDLcs,confirmed that estrogen could significantly promote the osteogenic capability of human PDLcs
(5)Our current study suggested that estrogen played an important role in periodontal diseases. Further studies will be necessary to delineate the actions of estrogen on periodontal ligament cells in detail.
引文
1. 谈智,王庭槐.雌激素作用分子机制研究进展.中国病理生理杂志 2003,19(10):1422-1426
2. 甘卫东,戴玉田,孙则禹.男性雌激素与骨代谢.中华男科学 2003,9(1):64-66
3. Simpson ER.Sources of estrogen and their importance.J Steroid Biochem Mol Bio 2003,86:225-230
4. Ivanova T , Beyer C . Ontogenetic expression and sex differences of aromatase and estrogen receptorα/βmRNA in the mouse hippocampus.Cell Tissue Res 2000,300:231-237
5. 黄朝晖,王金福.ERβ–一种新型的雌激素受体.生命科学 2000,12(3):126-129
6. 陈江,朱心强.雌激素受体和雄性生殖.国外医学卫生学分册 2003,30(5):257-261
7. Barnes CJ,Vadlamudi RK,Kumar R.Novel estrogen receptor coregulators and signaling molecules in human diseases.Cell Mol Life Sci 2004,61:281-291
8. Ogawa S,Inoue S,Watanabe T,et al.The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem Biophy Res Commu 1998,243:122-126
9. 孙晓光,甄璟然,孙建衡.雌激素作用机理的研究进展.中华妇产科杂志 2001,36(7):445-446
10. Lubahn DB,Moyer JS,Golding TS,et al.Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.Proc Natl Acad Sci USA 1993,90:11162-11166
11. Windahl SH,Hollberg K,Vidal O,et al.Female estrogen receptor beta-/- mice are partially protected against age-related trabecular bone loss.J Bone Miner Res 2001,16:1388-1398
12. Takano-Yamamoto T,Rodan GA. Direct effects of 17 beta-estradiol on trabecular bone in ovariectomized rats.Proc Natl Acad Sci USA 1990,87(6):2172-2176
13. Ralston SH.Analysis of gene expression in human bone biopsies by polymerase chain reaction:evidence for enhanced cytokine expression in postmenopausal osteoporosis.J BoneMiner Res 1994,9(6):883-890
14. Kimble RB,Srivastava S,Bellone C,et al.Estrogen inhibits IL-1 and TNF gene expression in transfected murine macrophagic cells.J Bone Miner Res 1996,11(Suppl. 1):235-241
15. Dinarello CA.The biological properties of interleukin-1.Eur Cytokine Network 1994,5:517-531
16. 安胜军,李恩.骨代谢过程中雌激素的作用及其与细胞因子的关系.国外医学生理病理科学与临床分册 1999,19(4):273-275
17. Girasole G,Jilka RL,Passeri G,et al.Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro : a potential mechanism for the antiosteoporotic effect of estrogens.J Clin Invest 1992,89(3):883-891
18. Lips P,Asscheman H,Uitewaal P,et al.The effect of cross-gender hormonal treatment on bone metabolism in male-to-female transsexuals.J Bone Miner Res 1989,4(5):657-662
19. 赵海波,夏志道,蔡国平,等.雌激素对实验性骨质疏松骨组织 I 型胶原和基质金属蛋白酶 9 表达的影响.中华老年医学杂志 1999,18(1):42-44
20. 罗湘杭,廖二元,邓小戈,等.雌二醇对正常成人成骨细胞基质金属蛋白酶及其抑制因子的影响.现代康复 2001,5(11):112-113
21. Komm BS.Estrogen binding receptor mRNA and biologic response in osteoblast-like osteosarcoma cells.Science 1988,241:81-84
22. Chander CL,Spector TD.Oestrogens,joint disease and cartilage.Ann Rheum Dis 1991,50(3):139-140
23. Classen H,Hornberger F,Ahrens KS,et al.The effect of estrogens and dietary calcium deficiency on the extracellular matrix of articular cartilage in Gottingen miniature pigs.Ann Anat 2002,184(2):141-148
24. Sowers MF,Hochberg M,Crabbe JP,et al.Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women.Am J Epidemiol 1996,143:38-47
25. 任永信,邓友章.雌激素对大鼠骨性关节炎影响的实验研究.中国修复重建外科杂志 2003,17(3):212-214
26. Spector TD,Perry LA,Jubb RW.Endogenous sex steroid levels in women with generalised osteoarthritis . Clin Rheumatol 1991,10:316-319
27. Cauley JA,Kwoh CK,Egeland G,et al.Serum sex hormones and severity of osteoarthritis of the hand.J Rheumatol 1993,20:1170-1175
28. 丁一,张举之. 牙周炎患者唾液孕酮、雌二醇、睾酮水平的初步观察. 中华口腔医学杂志 1991.26:287-290
29. Masayuki M, Masaharu M, Yoshifumi I. Effect of sex hormones on production of interleukin-1 by human peripheral monocytes. J Periodontol,1999,70(7):757-760
30. Tilakaratne M, Soory M. The modulation of androgen metabolism by estradiol,minocycline,and indomethacin in a cell culture model. J Periodontol,2002,73:585-590
31. Kimur AS,ELce J,Jellinck P. J Biochomic. 1983,213(1):165-169
32. Nordoryd M , Grossi S, Machtei EE, et al . JPeriodontol. 1993,64(10):957-962
33. Tilakaratne M, Soory M, Ranasighe AW,et al.Periodontal disease status during pregnancy and months post-partum, in a rural population of Sri-Lankan women. J Clin Periodontol 2000,27(10):753-757
34. 屠嫩斐,李哲光,游士奇,等.性激素类避孕药物对牙周组织影响的实验观察. 中华口腔医学杂志 1995,11(6):349-351
35. Krall EA,Garcia RI,Dawson-Hughes B.Increased risk of tooth loss is related to bone loss at the whole body, hip and spine.Calcif Tissue Int 1996,59(6):433-437
36. Taguchi A,Tanimoto K,Suei Y,et a1.Oral signs as indicators of possible osteoporosis in elderly women.Oral Pathol Oral Radiol Endod 1995,80(5):612-616
37. Earnshaw SA,Keating N,Hosking DJ,et al.Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women.EPIC study group Epidemiol 1998,27(3): 479-483
38. Payne J, Zachs B, Reinhardt RA, et al. The associationbetween estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis. J Periodontol 1997,68(1):24-31
39. Reinhardt RA, Payne JB, Maze CA,et al.Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in postmenopausal women.J Periodontol 1999,70(8):823-828
40. Ronderos M,Jacobs DR,Himes JH,et al.J Clin Periodontol 2000,27(10):778-786
41. Tazal M,Wactawski-Wende J,Sara G,et al.The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol 2000 , 71(10) :1492-1498
42. Streckfus CF,Johnson RB, Nick T,et a1.Comparison of alveolar bone loss , alveolar bone density and second metacarpal bone density,salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women.J Gerontol A Biol Sci Med Sci 1997,52(6):343-351
43. Moriya Y , Ito K , Murai S . Effects of experimentalosteoporosis on alveolar bone loss in rats.J Oral Sci 1998,40(4):171-175
44. 刘志民.性激素受体. 中华医学杂志 1997,77(4):312-313
45. Vittek J Henandez MR.Wenk EJ,et al.Specific estrogen receptors in human gingival. J Clin Endocrinal Metabol. 1982, 54:608-612
46. 韩守威,何斌,彭芝兰.人体正常骨及骨恶性肿瘤组织雌激素及孕激素受体分析. 中国病理生理学杂志 1993,9(1):97-99
47. 李幼华,陈少茂.性激素受体在牙龈瘤组织中的表达. 口腔医学 1999,6(2):70-72
48. Yih WY, Richardson L, Kratochvil FJ, et al..Expression of estrogen receptors in desquamative gingivitis. J Periodontol 2000,71(3):482-487
49. 冯雪, 陈富林, 任卫红等. 体外培养牙周膜成纤维细胞矿化能力的实验研究. 华西口腔医学杂志 1998 , 16 (4) : 294-296
50. Bolognia JL Aging skin. Am J Med 1995,98(suppl.): 99-100
51. Carta G, Ricciardi G, Effects of estradiol on in vitro cultures ofhuman fibroblasts. Minerva Ginecol 1992,44(1-2): 9-13
52. Comomi AE et al. Growth inhibition of fibroblasts by progesterone and medroxyprogesterone in vitro. Int Arch Allergy Appl Immunol 1985,76(2):97-100
53. Haczynski J, Tarkowski R, Jarzabek K et al. Differential effects of estradiol, raloxifene and tamoxifen on estrogen receptor expression in cultured human skin fibroblasts. Int J Mol Med 2004 ,13(6): 903-908
54. 吴玉家,鲁开化,张琳西等. 17-β 雌二醇、孕酮对增生性瘢痕成纤维细胞转化生长因子-β1 合成的影响. 中华医学美学美容杂志 2001,7(3):127-129
55. Jacobsson F.The treatment of keloids at radium hemmet.192l—l941.Acta Radiol l948,29:251-253
56. Muhmoud FH,Moustafa DCH,et al. Presumptive evidence of the effect of pregnancy estrogens on keloid growth.Plast Reconstr Surg 1975,56:450-453
57. Bincat,phd,Mrcog,E.et a1.Skin collagen changes in postmenopausal women receicing different regimens of estrogen therapy.Obstetrics & Gynecology 1987,70:l23-l27
58. Zhao Haibo,Xia zhidao,Cai Guoping,et a1.Expression of type-I collagen and matrix metalloproteinase-9 mRNA in born of castrated adult female rats:effects of estrogen.J Chin Med 1998,111(6):55l-555
59. Foster JS, Henley D C, Bukovsky Aet al.Multifaceted regulation of cell cycle progression by estrogen: regulationg of Cdk inhibitors and Cde25A independent of cyclin Dl—Cdk4 function. Mole and Cell Biol 200l,21(3):794-810
60. Watanabe T, Akishita M, He H et al. 17 beta-estradiol inhibits cardiac fibroblast growth through both subtypes of estrogen receptor. Biochem Biophys Res Commun 2003,311(2): 454-459
61. 李广智,凌洁. 导致缺牙的祸首是牙周疾病. 文汇报 2002,9月 16 日
62. 朱汉民. 老年骨质疏松症在我国的流行趋势. 实用老年医学 2000,14(3):115-118
63. 朱宪彝,郭世绂.代谢性骨病学 天津:天津科学技术出版社,1989:33
64. 刘忠厚 骨质疏松症 北京:化学工业出版社,1992.110
65. Gary TK,Monan S,Linkhart TA,et a1.Erstradiol stimulates in vitro the secretion of insulin—like growth factors by the elonal osteoblastic cell line UMR 106.Biochem Biophys Res Commun 1989;158:407-410
66. 程鹏,马绪臣.骨质疏松症大鼠颞下颌关节的骨组织形态计量学观察.中华口腔医学杂志 1999;34(5):300-302
67. 濑古和秀.性激素对大白鼠 13 腔黏膜的影响.日本口腔科学会杂志 l999;47(2):219-223
68. Erixsen,EF,Colvard DS,Berg NJ,et al.Evidence of estrogen receptors in normal human osteoblast—like cell.Science 1988;241(7):84-85
69. Lewko, W.M., Anderson, A. Estrogen receptors and growth response in cultured human periodontal ligament cells. Life Sci 1986,39:1201-1206
70. 李宏,张文昌 .雌激素受体α与β的比较. 福建医科大学学报 2005, 39(8)Suppl:23-25
71. 白玉兴.软骨组织中的性激素受体.北京口腔医学 1999,7(3):156--159
72. 陈书嫒,陆鸣,张长淮.免疫组化检测乳腺癌细胞雌孕激素受体胞浆着色原因的分析.诊断病理学杂志 1999,6(1):4-6
73. 李幼华,陈少茂.牙龈癌组织性激素受体免疫组化观察.中华口腔医学杂志 1998,33:17-19
74. Masood S. Estrogen and progesterone receptor in cytology:a comprehensive.Diag Cytopathol l992,8:475-478
75. Hall J M, Mcdonnell D P. ERβ-modulation of ERα transcription activity. Endocrinology 1999,140:5566-5578
76. Somerman MJ, Archer SY,Foster RA. Comparative Study of Human Periodontal Ligament Cells and Gingival Fibroblasts in vitro. J Dent Res 1988, 67(10): 66-70
77. Morishita M, Yamamura T, Shimazu A, et al. Estradiol enhances the production of mineralized nodules by human periodontal. J Clin Periodontol 1999,26(11):748-751.
78. Kuiper GG, Enmark E, Huikko M , et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996 ,93 (12) :59-69
79. Green S, Walter P, Kumar V, et al. Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature1986, 320: 134-139
80. Amar S. Implications of cellular and molecular biology advances in periodontal regeneration. Anat Rec 1996 ,245 (2) :361~373
81. Hurst A G, Goad D W,Mohan M. Independent downstream gene expression profiles in the presence of estrogen receptor alpha or beta. Archs oral Biol 2001,7(3):127-130
82. Nilsson S, MakelaS, Treuter E et al.Mechanisms of estrogen action. Physiol Rev 2001,81:1535–1565
83. Muramatsu M, Inoue S. Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun 2000,270:1–10
84. Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999,20:358–417
85. Jonsson D, Andersson G, Ekblad E,Liang M, Bratthall G, Nilsson B-O.Immunocytochemical demonstration of estrogen receptor b in human periodontal ligament cells. Arch Oral Biol 2004,49:85–88
86. Lowry, O.H., Roberts, N.R., Wu, M.L. et al The quantitative histochemistry of brain Ⅱ: eazyme measurement. J Biol Chem 1954, 207:19-37
87. Kuiper GGJM, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology 1997,138:863–870
88. Kuiper GGJM, Lemmen JG, Carlsson B et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b. Endocrinology 1998,139:4252–4263
89. Lindner V, Sung KK, Karas RH, Kuiper GGJM, Gustafsson J-A? .Mendelsohn ME. Increased expression of estrogen receptor-b mRNA in male blood vessels after vascular injury. Circ Res 1998,83:224–229
90. Morey AK, Pedram A, Razandi M et al. Estrogen and progesteron inhibit vascular smooth muscle proliferation. Endocrinology 1997;138:3330–3339
91. Mascarenhas P, Gapski R, Al-Shammari K, Wang H-L. Influence of sex hormones on the periodontium. J ClinPeriodontol 2003;30:671–681
92. Dyer RF, Sodek J, Heersche JNM. The effect of 17b-estradiol on collagen and noncollagenous protein synthesis in the uterus and some periodontal tissues.Endocrinology 1980;107:1014–1021
93. Surazynski A, Jarzabek K, Haczynski J, Laudanski P, Palka J, Wolczynski S. Differential effects of estradiol and raloxifene on collagen biosynthesis in cultured human skin fibroblasts. Int J Mol Med 2003;12:803–809
94. Barchiesi F, Jackson EK, Imthurn B, Fingerle J, Gillespie DG, Dubey RK. Differential regulation of estrogen receptor subtypes a and b in human aortic smooth muscle cells by oligonucleotides and estradiol. J Clin Endocrinol Metab 2004;89:2373–2381
95. Rosenbrock H,Seifert-Klauss V,Kaspar S,et a1.Changes of biochemical bone markers during the menopausal transition. Clin Chem Lab Med 2002,40(2):143-151
96. Toquet J,Rohanizadeh R,Guicheux J,et al,Osteogenic potential in vitro of human bone marrow cells cultured onmacroporous biphasic calcium phosphate ceramic J Biomed Mater Res l999,44(1):98-108
97. Bruder SP,Jaiswal N,Haynesworth SE.Growth kinetics self-renewal and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and fo11owing cryopreservation. J Cell Biochem l 997,64(2):278-294
98. Goseki M,Oida S,Takeda K,et a1.Identification of bone—type alkaline phosphatase mRNA from human periodontal ligarment ceils.J Dent Res 1995,74:31 9~322
99. D’Errico JA,MacNeil RL,Takata F,el a1.Expresioi1 of bone associated markers by tooth root lining cells,in situ and in vitro .Bone l997,20:117-126
100. 杨美祥,丁寅,徐如生,等.骨质疏松大鼠正畸牙齿移动过程中牙周组织的组织形态学观察 中国骨质疏松杂志1998,4(2);17-21